News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
KN495 updated clinical manuscript entitled “Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results” has been epublished by Nature Medicine on July 10
Photo from Jianda Yuan/Linkedin
Jul 17, 2023, 07:12

KN495 updated clinical manuscript entitled “Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results” has been epublished by Nature Medicine on July 10

In a post by

Attached and available through the link please find the ePublished version for your reference: https://lnkd.in/ewdfhzE6

Source:

biomarker cancer epublished immunotherapy Jianda Yuan OncoDaily Oncology pembrolizumab
Special Coverage
Blog
Feb 22, 2025, 04:49
Wafaa Rashed: Advancing Ethical and Evidence-Based Policy in Genomics
Blog
Feb 22, 2025, 04:42
Jessica Schubel: I'm launching my very own health care and aging policy consulting firm - Day One Strategies
Blog
Feb 22, 2025, 04:37
Karen Knudsen: Honored to be part of the Moffitt Cancer Center External Advisory Committee
Blog
Feb 22, 2025, 04:33
SPCC announced the upcoming launch of the "Digital Oncology" book series
Blog
Feb 22, 2025, 04:29
Results from the SIOPE OCEAN project are out
Blog
Feb 22, 2025, 04:25
Empower families to face their cancer journey with strength and hope - Cancer Hope Network
Blog
Feb 22, 2025, 04:19
Secure your spot for the CCI4EU Online Course by ESO
Blog
Feb 22, 2025, 04:16
Manchester Cancer Research Centre will continue its leadership in early detection science following the renewal of ACED
Blog
Feb 22, 2025, 04:12
Citrus Oncology is part of the 14 startups selected for the 2025 CancerX Accelerator
Science
Feb 22, 2025, 04:08
Anticancer potential of NO-Donor Oxadiazole in malignant pleural mesothelioma - The Babak Lab
Blog
Feb 22, 2025, 03:56
Early bird registration deadline for the 15th CCI Europe Conference approaches
Blog
Feb 22, 2025, 03:52
Share Your MASCC Guidelines Experience